A new trading day began on Friday, with Humana Inc (NYSE: HUM) stock price down -5.67% from the previous day of trading, before settling in for the closing price of $271.30. HUM’s price has ranged from $213.31 to $406.46 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 12.71% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 1.17%. With a float of $120.34 million, this company’s outstanding shares have now reached $120.64 million.
In an organization with 65680 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 88.39%, operating margin of 2.28%, and the pretax margin is 1.73%.
Humana Inc (HUM) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Healthcare Plans Industry. The insider ownership of Humana Inc is 0.28%, while institutional ownership is 97.11%. The most recent insider transaction that took place on Dec 31 ’24, was worth 948,925. In this transaction Chief Administrative Officer of this company sold 3,703 shares at a rate of $256.26, taking the stock ownership to the 8,181 shares. Before that another transaction happened on Dec 31 ’24, when Company’s Officer proposed sale 3,703 for $253.42, making the entire transaction worth $938,433.
Humana Inc (HUM) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 1.17% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 10.12% during the next five years compared to -13.05% drop over the previous five years of trading.
Humana Inc (NYSE: HUM) Trading Performance Indicators
Here are Humana Inc’s current performance indicators. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.26. Likewise, its price to free cash flow for the trailing twelve months is 12.91.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 9.96, a number that is poised to hit 9.50 in the next quarter and is forecasted to reach 13.87 in one year’s time.
Technical Analysis of Humana Inc (HUM)
Let’s dig in a bit further. During the last 5-days, its volume was 1.79 million. That was better than the volume of 1.71 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 54.26%. Additionally, its Average True Range was 11.58.
During the past 100 days, Humana Inc’s (HUM) raw stochastic average was set at 38.35%, which indicates a significant increase from 24.01% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 39.57% in the past 14 days, which was lower than the 50.70% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $271.08, while its 200-day Moving Average is $313.49. However, in the short run, Humana Inc’s stock first resistance to watch stands at $262.22. Second resistance stands at $268.54. The third major resistance level sits at $273.07. If the price goes on to break the first support level at $251.37, it is likely to go to the next support level at $246.84. Assuming the price breaks the second support level, the third support level stands at $240.52.
Humana Inc (NYSE: HUM) Key Stats
With a market capitalization of 30.87 billion, the company has a total of 120,411K Shares Outstanding. Currently, annual sales are 117,761 M while annual income is 1,207 M. The company’s previous quarter sales were 29,213 M while its latest quarter income was -693,000 K.
